G J Kolaja|P E Fast - JoVE Visualize

Showing results (11-20 of 24) with videos related to

Pageof 3

Sort By:

Journal of Acquired Immune Deficiency Syndromes|May 1, 1993

HIV vaccine trials: some design issues including sample size calculationD O Dixon, W N Rida, P E Fast, et al.

Research Communications in Chemical Pathology and Pharmacology|May 1, 1983

Alloxan-induced hyperglycemia in rats is reduced by 16,16-dimethyl-PGE2M J Ruwart, D W Sammons, G J Kolaja, et al.

Toxicologic Pathology|July 1, 1995

S-(1,2-dichlorovinyl)-L-cysteine-induced nephrotoxicity in the New Zealand white rabbit: characterization of proteinuria and examination of the potential role of oxidative injuryJ W Davis, D P Blakeman, R A Jolly, et al.

Journal of Clinical Microbiology|February 3, 2000

Genotypic stability of cold-adapted influenza virus vaccine in an efficacy clinical trialT A Cha, K Kao, J Zhao, et al.

Biomedical Chromatography : BMC|September 1, 1994

A non-radioactive iothalamate and p-aminohippuric acid high-performance liquid chromatographic method for simultaneously measuring glomerular filtration rate and renal blood flow in the ratR R Bell, P A Bombardt, D W DuCharme, et al.

Immunopharmacology|December 1, 1982

Effects of treatment with immunomodulatory drugs on thymus and spleen lymphocyte subpopulations and serum corticosterone levelsP E Fast, C A Hatfield, C L Franz, et al.

Vaccine|March 4, 2000

Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: implications for influenza epidemic controlI M Longini, M E Halloran, A Nizam, et al.

The Pediatric Infectious Disease Journal|December 12, 2001

Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected childrenJ C King, P E Fast, K M Zangwill, et al.

Annals of Internal Medicine|August 15, 1996

Safety and immunogenicity of a candidate HIV-1 vaccine in healthy adults: recombinant glycoprotein (rgp) 120. A randomized, double-blind trial. NIAID AIDS Vaccine Evaluation GroupB S Graham, M C Keefer, M J McElrath, et al.

The Journal of Infectious Diseases|February 11, 2000

Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adultsJ C King, J Treanor, P E Fast, et al.

Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:

Pageof 3

Journal of Acquired Immune Deficiency Syndromes|May 1, 1993

HIV vaccine trials: some design issues including sample size calculationD O Dixon, W N Rida, P E Fast, et al.

Research Communications in Chemical Pathology and Pharmacology|May 1, 1983

Alloxan-induced hyperglycemia in rats is reduced by 16,16-dimethyl-PGE2M J Ruwart, D W Sammons, G J Kolaja, et al.

Toxicologic Pathology|July 1, 1995

S-(1,2-dichlorovinyl)-L-cysteine-induced nephrotoxicity in the New Zealand white rabbit: characterization of proteinuria and examination of the potential role of oxidative injuryJ W Davis, D P Blakeman, R A Jolly, et al.

Journal of Clinical Microbiology|February 3, 2000

Genotypic stability of cold-adapted influenza virus vaccine in an efficacy clinical trialT A Cha, K Kao, J Zhao, et al.

Biomedical Chromatography : BMC|September 1, 1994

A non-radioactive iothalamate and p-aminohippuric acid high-performance liquid chromatographic method for simultaneously measuring glomerular filtration rate and renal blood flow in the ratR R Bell, P A Bombardt, D W DuCharme, et al.

Immunopharmacology|December 1, 1982

Effects of treatment with immunomodulatory drugs on thymus and spleen lymphocyte subpopulations and serum corticosterone levelsP E Fast, C A Hatfield, C L Franz, et al.

Vaccine|March 4, 2000

Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: implications for influenza epidemic controlI M Longini, M E Halloran, A Nizam, et al.

The Pediatric Infectious Disease Journal|December 12, 2001

Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected childrenJ C King, P E Fast, K M Zangwill, et al.

Annals of Internal Medicine|August 15, 1996

Safety and immunogenicity of a candidate HIV-1 vaccine in healthy adults: recombinant glycoprotein (rgp) 120. A randomized, double-blind trial. NIAID AIDS Vaccine Evaluation GroupB S Graham, M C Keefer, M J McElrath, et al.

The Journal of Infectious Diseases|February 11, 2000

Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adultsJ C King, J Treanor, P E Fast, et al.

Pageof 3